Cargando…
Multimodale Therapie des Hochrisiko- und lokal fortgeschrittenen Prostatakarzinoms
Treatment of the high-risk and locally advanced prostate cancer is a challenge in daily practice. At 20–40%, patients with such tumor stages currently make up the majority of patients at high-volume centers. Due to COVID-19, the proportion of patients with this tumor stage will probably continue to...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684888/ https://www.ncbi.nlm.nih.gov/pubmed/36413269 http://dx.doi.org/10.1007/s00120-022-01976-4 |